Today is: May 19, 2012

• Home
• Choosing a Personal Injury Lawyer
• News
  • Practice News
  • Breaking Legal News
• Auto Injury
  • Auto Injury
  • What to Do after an Auto Injury
• Trucking Accidents
  • Trucking Accidents
  • Causes of Trucking Accidents
  • What to Do after a Trucking Accident
  • Insurance Coverage for Trucking Accidents
  • Accident Investigation and Reconstruction
• Motorcycle Injury
  • Motorcycle Injury
  • What to Do after a Motorcycle Injury
  • Insurance Coverage for Motorcycle Accidents
• Construction Accidents
  • Construction Accidents
  • Types of Construction Accidents
  • Workers Compensation for Construction Accidents
  • OSHA Regulations
• Nursing Home Neglect
  • Nursing Home Neglect
  • The Rights of Nursing Home Residents
  • Signs of Nursing Home Neglect
• Birth Injury
  • Birth Injury
  • Causes of Birth Injury
  • Cerebral Palsy and Erb's Palsy
• Medical Malpractice
  • Medical Malpractice
  • Failure to Diagnose and Failure to Treat
• Your Case Review
• Ask an Attorney
• En Español
  • Inicio
  • Eleccion de un abogado especializado en lesiones personales
  • Evaluacion de Casos
  • Preguntar a un abogado
  • Lesiones automovilisticas
• Defective Drugs
  • Defective Drugs
  • List of Defective Drugs
  • Darvon Defective Drug

Search Our Website

Evaluate Your Case Today

* indicates a required field



* Type of Case Trucking Accidents Construction Accidents Nursing Home Neglect Birth Injury Medical Malpractice Auto Injury Motorcycle Injury Other
Message

MRI Agent Gadolinium

MRI Agent Gadolinium Linked to Dangerous Skin Disorder in Kidney Patients

In MRI (Magnetic Resonance Imaging) or MRA (Magnetic Resonance Angiography) scans, patients may be injected with a gadolinium-based contrast agent which can lead to a life-threatening skin disorder in kidney patients. Because kidney failure patients may be unable to filter the gadolinium out of their systems, a recently identified disorder called Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermotherapy (NSF/NFD) may develop. The FDA has warned against utilizing gadolinium-based contrast agents in kidney patients unless absolutely necessary, and if they are used, that the patient be put on dialysis immediately after the procedure. It is estimated that there are 200-500 cases of NSF / NFD worldwide. The FDA has received reports of 90 cases of NSF / NFD in kidney patients up until December, 2006.

Gadolinium-containing Contrast Agents

Following are the major gadolinium-based contrast agents used for MRI and MRA procedures.

• Magnevist
  • Generic: Gadopentetate Dimeglumine Injection
  • Manufacturer: Bayer HealthCare Pharmaceuticals/Schering AG/Berlex
• MultiHance
  • Generic: Gadobenate Dimeglumine
  • Manufacturer: Bracco Diagnostics
• Omniscan
  • Generic: Gadodiamide
  • Manufacturer: GE Healthcare
• OptiMARK
  • Generic: Gadoversetamide Injection
  • Manufacturer: Mallinckrodt/Tyco Healthcare
• ProHance
  • Generic: Gadoteridol Injection
  • Manufacturer: Bracco Diagnostics

Kidney Patients Have Legal Rights

• Are you a kidney failure patient who recently had an MRI or MRA?
• If you were administered a Gadolinium-based contrast agent during the MRI / MRA procedure and are now suffering from serious skin problems, you have legal rights.
• Kidney patients at risk for Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermotherapy are urged to contact us today for a FREE legal consultation.
• Our lawyers may be able to pursue a legal claim on behalf of Gadolinium victims. We collect NO legal fees whatsoever unless we win or settle your case.
• Call 1(800)WE-FIGHT to speak with a lawyer today, or fill out our Gadolinium case review form.

 

Return to Defective Drugs Listing